Depletion of CD4+ and CD8+ T cells reduces anti-cancer efficacy of IL-12 expressing NV1042, which is similar to anti-cancer effects of non-IL12-expressing NV1023, indicating IL-12 expression plays an important role in enhancing oncolytic efficacy through immune modulation [33]. Here, CD4 is linked to cancer.